Cleviprex®

DRUG2 trials

Sponsors

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd.

Conditions

Hypertensive Emergency

Phase 3

A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Hypertensive Emergency

Start: 2023-05-01End: 2025-06-01Target: 398Updated: 2023-03-24

a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency

Qilu Pharmaceutical (Hainan) Co., Ltd.Hypertensive Emergency

Start: 2023-07-15End: 2024-05-25Target: 378Updated: 2023-06-28